Standard No.:	T/CHATA 041-2024
English Name:	Regulation for the treatment of rifampicin-resistant tuberculosis
Chinese Name:	利福平耐药结核病治疗规范
Chinese Classification:	C05    Medical science
Professional Classification:	T/    Social Organization Standard
Source Content Issued by:	CHATA
Issued on:	2024-08-19
Implemented on:	2024-8-19
Status:	valid
Target Language:	English
File Format:	PDF

本文件规定了利福平耐药结核病长程治疗方案和短程治疗方案中抗结核药物、治疗方案制定原则、治疗方案调整原则、治疗期间监测、停止治疗指征和治疗转归分类。
本文件适用于各级疾病预防控制机构（结核病防治机构）、结核病定点医疗机构耐药结核病的规范化治疗方案制定和效果评价。